Organon (OGN) Other Working Capital Changes (2020 - 2026)
Organon (OGN) posted Other Working Capital Changes of $76.0 million for Q2 2026, up 406.67% on a QoQ basis from $15.0 million in Q1 2026, and up 193.83% year-over-year from $25.9 million in Q2 2025.
Analysis
Organon (OGN) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Organon has reported Other Working Capital Changes for 7 years, with the latest figure at $76.0 million in Q2 2026.
- On a quarterly basis, Other Working Capital Changes rose 193.83% year-over-year to $76.0 million in Q2 2026; TTM through Jun 2026 was $73.0 million, a 278.05% increase from a year earlier, with the FY2025 full-year figure at -$139.0 million, down 158.9% from the prior year.
- Other Working Capital Changes was $76.0 million for Q2 2026 at Organon, up from $15.0 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $99.0 million in Q2 2024, with the low at -$81.0 million in Q2 2025.
- Average Other Working Capital Changes over 5 years is $12.6 million, with a median of $15.0 million recorded in 2026.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes surged 861.54% in 2024, then plunged 181.82% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$33.0 million in 2022, then plunged by 118.18% to -$72.0 million in 2023, then soared by 177.78% to $56.0 million in 2024, then sank by 117.86% to -$10.0 million in 2025, then jumped by 860.0% to $76.0 million in 2026.
- The last three Other Working Capital Changes figures came in at $76.0 million (Q2 2026), $15.0 million (Q1 2026), and -$10.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 76.00 Mn |
| Jun 30, 2026 | 76.00 Mn |
| Mar 31, 2026 | 15.00 Mn |
| Mar 31, 2026 | 15.00 Mn |
| Dec 31, 2025 | -10.00 Mn |
| Dec 31, 2025 | -10.00 Mn |
| Sep 30, 2025 | -8.00 Mn |
| Sep 30, 2025 | -8.00 Mn |
| Jun 30, 2025 | -81.00 Mn |
| Jun 30, 2025 | -81.00 Mn |
| Mar 31, 2025 | -40.00 Mn |
| Mar 31, 2025 | -40.00 Mn |
| Dec 31, 2024 | 56.00 Mn |
| Dec 31, 2024 | 56.00 Mn |
| Sep 30, 2024 | 24.00 Mn |
| Sep 30, 2024 | 24.00 Mn |
| Jun 30, 2024 | 99.00 Mn |
| Jun 30, 2024 | 99.00 Mn |
| Mar 31, 2024 | 57.00 Mn |
| Mar 31, 2024 | 57.00 Mn |